Castellum (CTM) | Q4 2013 | 534,553.47% |
Lipocine (LPCN) | Q4 2013 | 22,608.87% |
Akari Therapeutics (AKTX) | Q4 2013 | 7,000% |
Tianci International, Inc Common Stock (CIIT) | Q4 2013 | 600% |
INVO Fertility (IVF) | Q4 2013 | 558.54% |
Enveric Biosciences (ENVB) | Q4 2013 | 385.39% |
Astrotech (ASTC) | Q4 2013 | 277.33% |
Fonar (FONR) | Q4 2013 | 265.06% |
Tenax Therapeutics (TENX) | Q4 2013 | 216.9% |
Electromed (ELMD) | Q4 2013 | 214.81% |
Oramed Pharmaceuticals (ORMP) | Q4 2013 | 151.71% |
SRx Health Solutions (SRXH) | Q4 2013 | 150% |
Camtek (CAMT) | Q4 2013 | 136.83% |
Sphere 3D (ANY) | Q4 2013 | 133.15% |
Precision Optics Corporation, Inc Common stock (POCI) | Q4 2013 | 125% |
Haoxi Health Technology Limited Class A Ordinary Shares (HAO) | Q4 2013 | 123.34% |
Coda Octopus (CODA) | Q4 2013 | 117.59% |
BOS Better Online Solutions (BOSC) | Q4 2013 | 115.28% |
Sellas Life Sciences (SLS) | Q4 2013 | 111.06% |
Perdoceo Education (PRDO) | Q4 2013 | 108.79% |
Universal Insurance (UVE) | Q4 2013 | 108.16% |
Plug Power (PLUG) | Q4 2013 | 106.67% |
ANI Pharmaceuticals (ANIP) | Q4 2013 | 102.4% |
Corcept Therapeutics (CORT) | Q4 2013 | 100.63% |
Marker Therapeutics (MRKR) | Q4 2013 | 100% |
